Company news

Sernova Biotherapeutics Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors

May 21, 2019

Sernova Announces Collaboration to Advance Therapeutic Cell Pouch Technologies for the Treatment of Hypothyroidism

April 30, 2019

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes

April 11, 2019

Sernova Corp Announces First Patient Implanted with Sernova's Cell Pouch(TM) in a Phase I/II US Clinical Trial for the Treatment of Hypoglycemia Unawareness in Subjects with Type 1 Diabetes

February 11, 2019

Sernova Announces the Appointment of Dr. David Lillicrap, M.D. to its Scientific Advisory Board

January 30, 2019

Sernova to Participate on Diabetes Panel and Present at NobleConXV, 15th Annual Investor Conference January 28th - 29th, 2019

January 28, 2019

Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I of II Cell Pouch Diabetes Clinical Trial

January 17, 2019

Sernova Announces Enrollment of First Patient in U.S. Phase I/II Study of Cell Pouch(tm) for Treatment in Type 1 Diabetes

December 20, 2018

Sernova Highlights Achievements from the HemAcure Consortium in Developing a Novel Cell-Based Therapy for Hemophilia A

November 20, 2018

Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing

November 9, 2018

Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy

November 6, 2018

Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A

October 23, 2018

Sernova Obtains FDA Notice of Allowance for Use of Proprietary Cell Pouch System with Continuous Glucose Monitoring Systems in Clinical Trials for Type 1 Diabetes - Video Available on Investmentpitch.com

February 23, 2018

Research Reports Initiated on Healthcare Stocks Titan Medical, Sernova, LED Medical Diagnostics, and Neovasc

February 13, 2017

SeeThruEquity Initiates Coverage on Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76

October 5, 2015

← Newer news releases

Decks

The 5 newest of 15 decks. Every deck is listed under its year.